Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder

Personalizing treatment for late-life depression requires identifying and integrating information from multiple factors that influence treatment efficacy (moderators). We performed exploratory moderator analyses using data from a multi-site, randomized, placebo-controlled, double-blind trial of arip...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Psychiatr Res
Main Authors: Smagula, Stephen F., Wallace, Meredith L., Anderson, Stewart J., Karp, Jordan F., Lenze, Eric J., Mulsant, Benoit H., Butters, Meryl A., Blumberger, Daniel M., Diniz, Breno S., Lotrich, Francis, Dew, Mary Amanda, Reynolds, Charles F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5021594/
https://ncbi.nlm.nih.gov/pubmed/27438687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpsychires.2016.07.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados